asa guidelines for glp 1 agonists A narrative review of glucagon-like peptide-1 receptor prior to deep sedation or general anesthesia Perioperative management of patients taking
Description
Empagliflozin (or another SGLT2 inhibitor) This is a once-daily pill that works to support weight loss through the kidneys rather than gut hormones

L.et al (2016)

[DOI] [PubMed] [Google Scholar] 45.FDA Approves Dulaglutide for Adults With T2D, Regardless of CVD

doi: 10.1038/ejcn.2011.223

Eligible patients were aged 66 years or older, were diagnosed with diabetes and had a minimum follow-up period of one year post diagnosis
